Yahoo Finance: How Will Mounjaro and Zepbound Sales Aid LLY's Upcoming Q1 Results? Eli Lilly's Q1 revenues are expected to reflect strong Mounjaro and Zepbound demand, as supply gains and global uptake offset pricing pressure. The Hill on MSN: Eli Lilly sues telehealth companies selling compounded Zepbound, Mounjaro Eli Lilly is suing four telemedicine companies selling compounded versions of its blockbuster obesity drug Zepbound and its diabetes treatment Mounjaro, escalating its battle against unauthorized ...

Understanding the Context

NBC Chicago: Most doses of Eli Lilly's Zepbound, Mounjaro in short supply through June, FDA says Stream NBC 5 for free, 24/7, wherever you are. All doses of Zepbound and Mounjaro besides the 2.5-milligram versions of both treatments are in a shortage. A previous update said some doses of both ... Most doses of Eli Lilly's Zepbound, Mounjaro in short supply through June, FDA says Common GLP-1s include semaglutides like Ozempic and Wegovy, and tirzepatides like Zepbound and Mounjaro.

Key Insights

These drugs work by mimicking a natural hormone to regulate appetite, blood sugar, and feelings ...